Inhibitors of farnesyl:protein transferase—A possible cancer chemotherapeutic
- 1 September 1996
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 4 (9) , 1537-1543
- https://doi.org/10.1016/0968-0896(96)00146-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Farnesyl Group of H-Ras Facilitates the Activation of a Soluble Upstream Activator of Mitogen-activated Protein KinasePublished by Elsevier ,1995
- Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceNature Medicine, 1995
- Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product releaseBiochemistry, 1995
- Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkagesBioorganic & Medicinal Chemistry, 1994
- Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motifBioorganic & Medicinal Chemistry Letters, 1994
- Conformation of a heptapeptide substrate bound to protein farnesyltransferaseBiochemistry, 1993
- Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: Interactive binding between substrates and a preferred kinetic pathwayBiochemistry, 1993
- Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity.Proceedings of the National Academy of Sciences, 1992
- The ras protein family: evolutionary tree and role of conserved amino acidsBiochemistry, 1991
- Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptidesCell, 1990